Ypsomed Holding AG (LTS:0QLQ) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 03, 2026)


LTS:0QLQ Ypsomed Holding AG LTS:0QLQ
82 GF Score
Price CHF359.40
GF Value CHF397.17
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Ypsomed Holding AG's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

LTS:0QLQ vs ISRG, BDX, MDLN: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ypsomed Holding AG Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Margin of Safety % (DCF Earnings Based) falls into.


LTS:0QLQ
82GF Score
Ypsomed Holding AG LTS:0QLQ
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF359.40 is trading 9.5% below its estimated GF Value™ of CHF397.17. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for LTS:0QLQ:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: CHF397.17 vs. price of CHF359.40 (9.5% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
82GF Score

Get the complete analysis for LTS:0QLQ

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF359.40
Price
CHF397.17
GF Value